Pyroptosis-Related Signature as Potential Biomarkers for Predicting Prognosis and Therapy Response in Colorectal Cancer Patients

被引:10
|
作者
Li, Zhiyong [1 ,2 ]
Liu, Yang [1 ,3 ]
Lin, Baiqiang [1 ]
Yan, Wei [1 ]
Yi, Huijie [4 ,5 ]
Wang, Haoran [1 ]
Wei, Yunwei [1 ,3 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Oncol & Endoscop Surg, Harbin, Peoples R China
[2] Heilongjiang Acad Med Sci, Translat Med Res & Cooperat Ctr Northern China, Harbin, Peoples R China
[3] Univ Chinese Acad Sci, HwaMei Hosp, Pancreat & Gastrointestinal Surg Div, Ningbo, Peoples R China
[4] Peking Univ, Sch Nursing, Beijing, Peoples R China
[5] Peking Univ, Resp & Crit Care Med, Peoples Hosp, Beijing, Peoples R China
关键词
colorectal cancer; pyroptosis; prognostic; genetic alteration; immune cell infiltration; single-cell sequencing; TUMOR MICROENVIRONMENT; EXPRESSION; CLEAVAGE; ACTIVATION; CELLS; GSDMD;
D O I
10.3389/fgene.2022.925338
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Abnormal mucosal inflammation is a critical risk factor for pathogenesis and progression of colorectal cancer (CRC). As a type of proinflammatory death, pyroptosis can recast a suitable microenvironment to promote tumor growth. However, the potential role of pyroptosis in CRC remains unclear.Methods: A total of 38 pyroptosis-related gene (PRG) expression profiles and clinical information were collected from multiple public datasets. Bioinformatics methods were used to analyze the clinical significance, functional status, immune infiltration, genomic alteration, and drug sensitivity in different subgroups. Whole-genome microarray analysis was performed to analyze the regulation of gut microbiota on the expression of PRGs.Results: Two distinct molecular subtypes were identified and suggested that multilayer PRG alterations were associated with patient clinicopathological features, prognosis, and tumor microenvironment (TME) infiltrating characteristics. Furthermore, we obtained eight PRG signatures by applying differential expression analysis and univariate Cox and Lasso regression analyses. A risk prognosis model was constructed for predicting overall survival (OS) and recurrence-free survival (RFS) based on the PRG signature. There were significant differences in clinical characteristics, 22 immune cells, and immune functions between the high- and low-risk groups. In addition, the PRG signature was significantly associated with the microsatellite instability (MSI), tumor mutation burden (TMB), cancer stem cell (CSC) index, immunotherapeutic characteristics, and chemotherapeutic drug sensitivity. Moreover, the in vitro experiments had shown that Fusobacterium nucleatum (F.n) could affect the CASP6 expression, which was associated with the chemoresistance to 5-fluorouracil (5-Fu) in CRC.Conclusion: Our findings provided a foundation for future research targeting pyroptosis and a new insight into the prognosis and immune cell infiltration of CRC, and they suggested that F.n might influence CRC progression through pyroptosis.
引用
收藏
页数:25
相关论文
共 50 条
  • [31] Pyroptosis-Related lncRNAs Predict the Prognosis and Immune Response in Patients With Breast Cancer
    Yang, Xia
    Weng, Xin
    Yang, Yajie
    Jiang, ZhiNong
    [J]. FRONTIERS IN GENETICS, 2022, 12
  • [32] A Pyroptosis-Related Gene Signature for Predicting Survival in Glioblastoma
    Li, Xin-Yu
    Zhang, Lu-Yu
    Li, Xue-Yuan
    Yang, Xi-Tao
    Su, Li-Xin
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [33] A Novel Pyroptosis-Related Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Osteosarcoma
    Zhang, Yiming
    He, Rong
    Lei, Xuan
    Mao, Lianghao
    Jiang, Pan
    Ni, Chenlie
    Yin, Zhengyu
    Zhong, Xinyu
    Chen, Chen
    Zheng, Qiping
    Li, Dapeng
    [J]. FRONTIERS IN GENETICS, 2021, 12
  • [34] A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma
    Yu, Haochen
    Fu, Yong
    Tang, Zhenrong
    Jiang, Linshan
    Qu, Chi
    Li, Han
    Tan, Zhaofu
    Shu, Dan
    Peng, Yang
    Liu, Shengchun
    [J]. AGING-US, 2022, 14 (02): : 989 - 1013
  • [35] Identification of a Pyroptosis-Related Gene Signature for Predicting the Immune Status and Prognosis in Lung Adenocarcinoma
    Gong, Zetian
    Li, Qifan
    Yang, Jian
    Zhang, Pengpeng
    Sun, Wei
    Ren, Qianhe
    Tang, Junjie
    Wang, Wei
    Gong, Hui
    Li, Jun
    [J]. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [36] RSAD2, a pyroptosis-related gene, predicts the prognosis and immunotherapy response for colorectal cancer
    Li, Yunxiao
    Cui, Qianqian
    Zhou, Bin
    Zhang, Jiayu
    Guo, Rong
    Wang, Yanyan
    Xu, Xinhua
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (05):
  • [37] Identification of pyroptosis-related lncRNA subtype and signature predicts the prognosis in bladder cancer
    Zeng, Tao
    Ye, Jianzhong
    Wang, Heng
    Tian, Wen
    [J]. MEDICINE, 2023, 102 (42) : E35195
  • [38] A pyroptosis-related gene signature that predicts immune infiltration and prognosis in colon cancer
    Wu, Mingjian
    Hao, Shuai
    Wang, Xiaoxiang
    Su, Shuguang
    Du, Siyuan
    Zhou, Sitong
    Yang, Ronghua
    Du, Hanpeng
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [39] Nine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma
    Liang, Deku
    Hu, Min
    Tang, Qin
    Huang, Mao
    Tang, Liangdan
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 8073 - 8085
  • [40] A pyroptosis-related lncRNA signature in bladder cancer
    Wang, Peng
    Wang, Zhiqiang
    Zhu, Liping
    Sun, Yilan
    Castellano, Leandro
    Stebbing, Justin
    Yu, Zhentao
    Peng, Ling
    [J]. CANCER MEDICINE, 2023, 12 (05): : 6348 - 6364